Skip to main content
OpenTrials
Completed

NCT Number: NCT04071301

Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence

This study is an explorative, open, single-arm clinical investigation to collect real-life measurement data in order to assess the mathematical algorithms involved in TENA SmartCare Change Indicator.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The purpose of this exploratory clinical investigation is to evaluate safety and to collect real-life measurement data using the TENA SmartCare Change Indicator. The collected data will be used to assess the device related algorithms. These algorithms have been established and verified in a laboratory environment. However, due to possible differences in parameters, real-life measurement data are to be collected to aid in further product development.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject is willing and able to provide informed consent and to participate in the clinical investigation.
  • The subject is ≥18 years of age.
  • The subject is diagnosed with urinary incontinence.
  • The subject is being cared for at Tre Stiftelser.

Exclusion criteria

  • The subject has ≥ 4 fecal "incidences" per week.
  • The subject has severe absorbent product related skin problems, as judged by the investigator.
  • The subject is hyper sensitive related to allergic reaction to any of the included materials, as judged by the investigator.
  • The subject has ≥ 2 intermittent urinary catheters per day.
  • The subject has a pacemaker or an implantable cardioverter-defibrillator.
  • The subject removes the incontinence product.
  • The subject demonstrates responsive behavior towards sensors.
  • The subject has any other condition that may make participation in the clinical investigation inappropriate, as judged by investigator.
  • The subject is not cared for at Tre Stiftelser.
  • The subject is pregnant or lactating.

Treatment and study plan

TENA SmartCare Change Indicator

Device

Each participating subject will be provided with a Change Indicator and absorbent products for the duration of the investigation. Nine types of absorbent products will be used to collect real-life measurement data in order to assess the mathematical algorithms involved in the TENA SmartCare Change Indicator. Each participating subject will be allocated to the type(s) that are considered most suitable.

Gateways will be placed in the resident's rooms as well as in common areas, this to enable full measurement registration.

Primary outcomes

  1. Urine Volume Quantification and Impedance Measurements

    Time frame: 11 weeks

    Descriptive statistics were used to summarize any individual differences between the predicted urine volume from the Change Indicator and the true urine volume (by measuring absorbent product weight). A measure of mean difference for the predicted volume minus true volume is assessed. A combination of these values were used to assess the mathematical algorithms for the TENA SmartCare Change Indicator.

Sponsors and collaborators

Lead sponsor

Essity Hygiene and Health AB

Industry

Registry information

Official study title

An Explorative, Open, Single-arm Clinical Investigation to Collect Real-life Measurement Data in Order to Assess the Mathematical Algorithms Involved in TENA SmartCare Change Indicator.

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Aug 28, 2019
Registry last updated
Jun 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.